The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

Multiple myeloma (MM) is a plasma cell malignancy comprising 10% of hematologic cancers, associated with bone marrow dysfunction and organ damage. High-risk cytogenetic MM patients, identified by specific genetic abnormalities, face poor outcomes despite recent advancements. Traditional treatments o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in medicine Jg. 12; S. 1575914
Hauptverfasser:	Zhou, Huixing, Chen, Wenming
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 13.05.2025
Schlagworte:	CD38 antibodies high-risk cytogenetics Medicine minimal residual disease multiple myeloma novel drug regimens progression-free survival multiple myeloma novel drug regimens progression-free survival CD38 antibodies meta-analysis minimal residual disease systematic review high-risk cytogenetics
ISSN:	2296-858X, 2296-858X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!